We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease (COPD) (BEAM COPD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01551953
Recruitment Status : Completed
First Posted : March 13, 2012
Last Update Posted : February 27, 2017
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
Gloria Y. Yeh, Beth Israel Deaconess Medical Center

Brief Summary:
The main purpose of this study is to determine feasibility and effects of tai chi and mind-body breathing in patients with COPD.

Condition or disease Intervention/treatment Phase
Chronic Obstructive Pulmonary Disease (COPD) Behavioral: Tai chi Behavioral: Mind-body breathing Behavioral: Education Phase 2

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 124 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Other
Official Title: BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease
Study Start Date : February 2011
Primary Completion Date : April 2016
Study Completion Date : April 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: COPD Lung Diseases
U.S. FDA Resources

Arm Intervention/treatment
Experimental: tai chi exercise Behavioral: Tai chi
12 week tai chi class
Experimental: mind-body breathing Behavioral: Mind-body breathing
12 week breathing class
Active Comparator: education Behavioral: Education
12 week education class



Primary Outcome Measures :
  1. Feasibility of tai chi intervention [ Time Frame: 12 weeks ]
    Willingness to participate, adherence, and safety


Secondary Outcome Measures :
  1. Change from baseline- Disease specific quality of life [ Time Frame: baseline, 12 weeks, 24 weeks ]
    Chronic Respiratory Questionnaire

  2. Change from baseline- Exercise capacity [ Time Frame: baseline, 12 weeks, 24 weeks ]
    six-minute walk distance, cardiopulmonary exercise testing

  3. Change from baseline- Dyspnea [ Time Frame: baseline, 12 weeks, 24 weeks ]
    UCSD Shortness of Breath Questionnaire

  4. Change from baseline- Psychosocial well-being [ Time Frame: baseline, 12 weeks, 24 weeks ]
    CES-D, Perceive Stress Scale, COPD Self-Efficacy Scale, Multidimensional Scale of Percieved Social Support

  5. Change from baseline- Pulmonary function [ Time Frame: baseline, 12 weeks, 24 weeks ]
    Spirometry and lung volumes

  6. Change from baseline- Physical strength and flexibility [ Time Frame: baseline, 12 weeks, 24 weeks ]
    Chair Sit and Reach, Chair Stand



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Moderate-severe COPD
  2. Age ≥ 40 years

Exclusion Criteria:

  1. Subjects with respiratory failure or GOLD stage 4 who are unable to safely perform a 6 minute walk test or otherwise safely exercise as deemed by a physician.
  2. COPD exacerbation requiring steroids, antibiotics, ED visit or hospitalization within the past 2 weeks unless physician deems subject at baseline
  3. Planned major pulmonary intervention within the next 3 months
  4. Hypoxemia on walk test or cardiopulmonary exercise test
  5. Inability to ambulate due to vascular or other neuromuscular conditions that would preclude a walk test
  6. Clinical signs of unstable cardiovascular disease
  7. Severe cognitive dysfunction
  8. Non-English speaking
  9. Current active participation in pulmonary rehabilitation program or current regular practice of tai chi
  10. Physician diagnosis of unstable/untreated clinical depression
  11. History of lung cancer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01551953


Locations
United States, Massachusetts
VA Healthcare System
Boston, Massachusetts, United States, 02130
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
National Institutes of Health (NIH)
National Center for Complementary and Integrative Health (NCCIH)
Investigators
Principal Investigator: Gloria Yeh, MD, MPH BIDMC, Harvard Medical School

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Gloria Y. Yeh, Associate Professor of Medicine, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT01551953     History of Changes
Other Study ID Numbers: 2010P000412
R01AT005436 ( U.S. NIH Grant/Contract )
First Posted: March 13, 2012    Key Record Dates
Last Update Posted: February 27, 2017
Last Verified: February 2017

Keywords provided by Gloria Y. Yeh, Beth Israel Deaconess Medical Center:
chronic bronchitis
emphysema
pulmonary
COPD

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases